TickerFacts.

Vitaspring Biomedical Co. Ltd. (VSBC): Revenue

Annual figures by period end, from SEC filings.

$0
Year ended 2026-01-31
$0
Trailing 12 months to 2026-07-31
$5.61M2017-01-31: $02018-01-31: $16.2K2019-01-31: $17.2K2020-01-31: $15.1K2021-01-31: $248.2K2022-01-31: $5.61M2023-01-31: $02024-01-31: $02025-01-31: $02026-01-31: $0$0
2017-01-31 Revenue (USD) 2026-01-31
Period endedRevenueChange YoYSource filing
2026-01-31$0n/a2026-06-17, From 2025-02-01
2025-01-31$0n/a2026-06-17, From 2024-02-01
2024-01-31$0n/a2026-06-08, From 2023-02-01
2023-01-31$0-100.0%2026-03-12, From 2022-02-01
2022-01-31$5.61Mn/m2025-12-01, From 2021-02-01
2021-01-31$248.2Kn/m2022-05-03, From 2020-02-01
2020-01-31$15.1K-11.9%2021-04-14, From 2019-02-01
2019-01-31$17.2K+5.9%2020-06-09, From 2018-02-04
2018-01-31$16.2Kn/a2019-04-26, From 2017-02-01
2017-01-31$0n/a2018-05-16, From 2016-02-01

Revenue at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Vitaspring Biomedical Co. Ltd. (VSBC)2026-01-31$0n/a
NRC Health (NRC)2025-12-31$137.39M-4.0%
Incyte Corp (INCY)2025-12-31$5.14B+21.2%
Icon PLC (ICLR)2025-12-31$8.25B+0.8%
Charles River Laboratories International, Inc. (CRL)2025-12-27$4.02B-0.9%
MaxCyte, Inc. (MXCT)2025-12-31$33.03M-14.5%
Cannabis Bioscience International Holdings, Inc. (CBIH)2025-05-31$303.0K+21.8%
Iqvia Holdings Inc. (IQV)2025-12-31$16.31B+5.9%
iSpecimen Inc. (ISPC)2025-12-31$1.93M-79.2%

Compare VSBC, NRC, INCY, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗